Status | Study |
Recruiting |
Study Name: A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas Condition: Adenocarcinoma of the Cervix Adenosquamous Cell Carcinoma of th Date: 2016-05-02 Interventions: Drug: Pemetrexed Pemetrexed 500 mg/m2 Other Name: Al |
Recruiting |
Study Name: The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial Condition: Uterine Cervical Neoplasms Squamous Cell Carcinoma Adenoca Date: 2015-03-16 Interventions: Drug: Metformin Drug: Cisplatin |
Active, not recruiting |
Study Name: Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Date: 2014-10-02 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer Condition: Metastatic Non-Small Cell Lung Cancer Squamous Cell Carcinoma Date: 2014-05-06 Interventions: Drug: Aldesleukin Aldesleukin |
Active, not recruiting |
Study Name: Hybrid PET/MR in the Therapy of Cervical Cancer Condition: Cervix Carcinoma Cervical Squamous Cell Carcinoma Cervical Date: 2012-12-17 Interventions: Procedure: FDG PET/MR Participants will undergo a FDG, gadolinium enhanced PET/MR scan. |
Active, not recruiting |
Study Name: Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix Condition: Cervical Squamous Cell Carcinoma Adenosquamous Carcinoma Date: 2011-06-01 Interventions: Procedure: Extraperitoneal laparoscopic lymphadenectomy (EPLND) |
Terminated |
Study Name: Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer Condition: Stage IB2 Cervical Cancer Stage II Cervical Cancer Adenoca Date: 2011-05-05 Interventions: Procedure: hysterectomy |
Withdrawn |
Study Name: Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) Condition: Carcinoma Adenocarcinoma Uterine Cervix Date: 2011-02-21 Interventions: Drug: Nimotuzumab Nimotuzumab, |
Completed |
Study Name: Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Date: 2011-01-21 Interventions: Drug: Cisplatin Given IV |
Completed |
Study Name: Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Date: 2010-12-24 Interventions: Drug: Brivanib Alaninate Given |